Compare LMRI & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMRI | SVRA |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.4B |
| IPO Year | 2025 | N/A |
| Metric | LMRI | SVRA |
|---|---|---|
| Price | $18.63 | $6.63 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $6.88 |
| AVG Volume (30 Days) | ★ 3.9M | 3.2M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,003,375,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.03 | $1.89 |
| 52 Week High | $19.25 | $7.01 |
| Indicator | LMRI | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 70.55 |
| Support Level | N/A | $5.55 |
| Resistance Level | N/A | $7.01 |
| Average True Range (ATR) | 0.00 | 0.46 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 0.00 | 79.11 |
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.